Chardan Capital Downgrades EyePoint to Neutral, Lowers Price Target to $5
Benzinga Newsdesk 2 months ago
NewsDowngradesAnalyst RatingsPrice Target
Chardan Capital analyst Andreas Argyrides downgrades EyePoint (NASDAQ:EYPT) from Buy to Neutral and lowers the price target from $65 to $5.
Chardan Capital analyst Andreas Argyrides downgrades EyePoint (NASDAQ:EYPT) from Buy to Neutral and lowers the price target from $65 to $5.